C12R 2001/82
Penicillium chrysogenum
C12R2001/82 (Penicillium chrysogenum) appears on 9 US grants and 6 published applications in this corpus.
Search patents in C12R- Granted patents
- 9
- Published applications
- 6
- Assignees
- 9
- Inventors
- 31
- Latest grant
- 23 May 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 2 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Filamentous fungal mutants with improved homologous recombination efficiency23 May 2017US 9,657,301 B2Dsm IP Assets B.V.
- Formylated xanthocillin analogues as neuroprotective agents27 Sep 2016US 9,453,004 B2Neuron Biopharma, S.A.
- Filamentous fungal mutants with improved homologous recombination efficiency26 Jan 2016US 9,243,043 B2Dsm IP Assets B.V.
- Nitrate reductase as marker for filamentous fungi12 Apr 1994US 5,302,527 AGlaxo Group Limited
- 2-(Allenyl)penicillins6 Sep 1988US 4,769,325 A
- Compositions and methods for the isolation and purification of anti-fungal protein from epichloe festucae and use thereof for reducing symptoms of dollar spot disease in targeted plant species31 Jul 2025US 2025/0243249 A1Rutgers, The State University of New Jersey
- An enzymatic pre-treatment method for efficient saccharification of lignocellulosic materials13 Jun 2024US 2024/0191268 A1Praj Industries Limited
- Compositions including filamentous fungal biomass and cultured animal cells, and methods of forming and using7 Mar 2024US 2024/0074478 A1The Regents of the University of California
- Filamentous fungal mutants with improved homologous recombination efficiency12 May 2016US 2016/0130589 A1Dsm IP Assets B.V.
- Formylated xanthocillin analogues as neuroprotective agents8 Jan 2015US 2015/0011621 A1Neuron Biopharma, S.A.
Most cited
By later US patents
- Nitrate reductase as marker for filamentous fungi76US 5,302,527 AGlaxo Group Limited · 1994
- Method of treating a biomass18US 4,067,821 ACeskoslovenska komise pro atomovou energii · 1978
- Peptide substituted penicillins3US 4,722,924 ANational Research Development Corporation · 1988
- Use of phenoxyalkanes as precursors in penicillin V fermentation1US 4,250,258 AE. R. Squibb & Sons, Inc. · 1981